Company Monitoring Page for Astellas

latest headlines for company on cafepharma

Bayer cues up filings for rival to Astellas’ menopause drug
Pharmaphorum
Tue, 03/19/24 - 11:35 am
Tags:
Bayer, elinzanetant, menopause, hot flashes, Veozah, Astellas
Astellas puts the cork back in $350M Xork deal after Cartesian-Selecta merger
Fierce Biotech
Thu, 03/14/24 - 06:22 pm
Tags:
Astellas, Cartesian Therapeutics, Xork, Pompe disease
Astellas-owned Xyphos offers more than $800M for Kelonia's in vivo delivery know-how
Fierce Biotech
Thu, 02/15/24 - 07:21 pm
Tags:
Xyphos Biosciences, Astellas, Kelonia, R&D
Pharma showed up for the big game
Axios
Mon, 02/12/24 - 10:27 am
Tags:
Astellas, Pfizer, Super Bowl, pharma advertising
Astellas adds digital to its top management team
Pharmaphorum
Thu, 02/8/24 - 11:05 am
Tags:
Astellas, digital pharma
Astellas' sales expectations are up for Padcev, down for Veozah
Fierce Pharma
Mon, 02/5/24 - 11:02 pm
Tags:
Astellas, earnings, Padcev
FDA declines to approve Astellas' gastric cancer drug
Reuters
Tue, 01/9/24 - 09:39 am
Tags:
Astellas, FDA, gastric cancer, zolbetuximab
Astellas strikes $1.7bn SIRP drug deal with Elpiscience
Pharmaphorum
Tue, 01/2/24 - 09:56 am
Tags:
Astellas, Elpiscience, immunotherapy, macrophages
Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer
Fierce Pharma
Tue, 12/19/23 - 10:26 am
Tags:
Merck, Astellas, Pfizer, Keytruda, Padcev, bladder cancer
FDA starts review of Padcev/Keytruda for bladder cancer
Pharmaphorum
Fri, 12/1/23 - 09:35 am
Tags:
Merck, Astellas, Seagen, Padcev, bladder cancer, FDA, priority review
Astellas builds case for menopause drug fezolinetant
Pharmaphorum
Thu, 11/30/23 - 09:54 am
Tags:
Astellas, menopause, fezolinetant
Xtandi cleared by FDA for earlier-stage prostate cancer
Pharmaphorum
Fri, 11/17/23 - 10:10 am
Tags:
Pfizer, Astellas, Xtandi, prostate cancer, FDA
Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff
Fierce Biotech
Thu, 11/16/23 - 11:45 am
Tags:
Astellas, Propella Therapeutics, M&A, JNJ, Zytiga, prostate cancer
Astellas Sees Path Forward for Gene Therapy Despite Four Patient Deaths
BioSpace
Thu, 11/16/23 - 11:36 am
Tags:
Astellas, AT132, patient deaths, FDA, X-linked myotubular myopathy
Astellas’ Izervay reduces GA lesion growth in Phase III trial
Clinical Trials Arena
Mon, 11/6/23 - 09:51 am
Tags:
Astellas, Izervay, geographic atrophy, age-related macular degeneration, clinical trials
A New Drug For Menopausal Hot Flashes, Veozah, Faces Access Challenges
Forbes
Tue, 10/24/23 - 07:49 pm
Tags:
Astellas, hot flashes, menopause, Veozah, access
ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer
Fierce Pharma
Wed, 10/18/23 - 11:38 am
Tags:
Seagen, Astellas, Merck, Padcev, Keytruda, bladder cancer, ESMO
Astellas rolls out national Veozah campaign for treating menopause symptoms
Medical Marketing and Media
Mon, 10/9/23 - 10:04 am
Tags:
Astellas, Veozah, menopause, hot flashes, TV ads, DTC ads
Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study
BioSpace
Thu, 09/28/23 - 10:33 am
Tags:
NEJM, clinical trials, Duchenne Muscular Dystrophy, patient deaths, Astellas, Pfizer
Astellas Withdrew Its Inflation Reduction Act Lawsuit—Will Other Companies Follow?
BioSpace
Wed, 09/27/23 - 11:09 pm
Tags:
Astellas, legal, Inflation Reduction Act

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.